Clinical Characteristics of Treatment-seeking Prescription Opioid Vs. Heroin-using Adolescents with Opioid Use Disorder
Overview
Authors
Affiliations
Objectives: To compare the clinical characteristics of treatment-seeking prescription opioid-using adolescents with DSM-IV opioid use disorder (OUD) to those with heroin-using OUD adolescents.
Method: We analyzed the data on OUD adolescents (94, ages 14-18 years) extracted from the parent study dataset comparing clinical characteristics of treatment-seeking OUD to non-OUD adolescents from a adolescent substance abuse treatment program in Baltimore, MD. The sample consisted of 41 non-heroin prescription opioid-using and 53 heroin-using OUD adolescents who were assessed cross-sectionally using standardized interviews and self-reports. Chi-square and t-tests were performed to determine group differences on demographic, substance use, psychiatric and HIV-risk behaviors.
Results: Both groups were older (mean 17 years), predominantly Caucasian, and had a suburban residence; they had high rates of co-occurring psychiatric disorders (83%) and they reported moderately high depression symptoms. The heroin-using sample was more likely to have dropped out of school, be dependent on opioids and inject drugs using needles. The prescription opioid-using OUD youth were more likely to meet criteria for multiple SUDs (including prescription sedatives and psychostimulants), current ADHD and report selling drugs; and more likely to be court ordered to current treatment and report prior psychiatric treatment.
Conclusions: Both groups of treatment-seeking OUD adolescents had multiple comorbidities but there were substantial differences between prescription opioid-users and heroin-users. These differences may suggest different prognoses and treatment implications. Future research may shed light on the factors leading to differences in choice of opioids and their impact on treatment outcomes; and assess the role of agonist assisted treatments and integrated psychiatric care.
"You get stuck in it": Young people's accounts of attempting to quit non-medical tramadol use.
Arve K Nordisk Alkohol Nark. 2023; 40(4):355-370.
PMID: 37663056 PMC: 10472933. DOI: 10.1177/14550725231160330.
Vold J, Halmoy A, Chalabianloo F, Pierron M, Loberg E, Johansson K BMC Psychiatry. 2023; 23(1):479.
PMID: 37386438 PMC: 10308780. DOI: 10.1186/s12888-023-04980-w.
Welsh J, Sitar S, Hunter B, Godley M, Dennis M Drug Alcohol Depend. 2023; 246:109850.
PMID: 36989708 PMC: 10121859. DOI: 10.1016/j.drugalcdep.2023.109850.
Health harms of non-medical prescription opioid use: A systematic review.
Werb D, Scheim A, Soipe A, Aeby S, Rammohan I, Fischer B Drug Alcohol Rev. 2022; 41(4):941-952.
PMID: 35437841 PMC: 9064965. DOI: 10.1111/dar.13441.
Sarkar S, Singh R, Sharma A, Pandit M, Gupta R, Singhal D Cureus. 2021; 13(11):e19310.
PMID: 34900485 PMC: 8647861. DOI: 10.7759/cureus.19310.